Abstract

The increase in the number of people suffering diabetes has been the driving force behind the development of glucose sensors to overcome the current testing shortcomings. In this work, a reusable, non-invasive and ultrafast radio frequency biosensor based on optimized integrated passive device fabrication process for quantitative detection of glucose level was developed. With the aid of the novel biosensor design with hammer-shaped capacitors for carrying out detection, both the resonance frequency and magnitude of reflection coefficient can be applied to map the different glucose levels. Meanwhile, the corresponding fabrication process was developed, providing an approach for achieving quantitative detection and a structure without metal-insulator-metal type capacitor that realizes low cost and high reliability. To enhance the sensitivity of biosensor, a 3-min dry etching treatment based on chlorine/argon-based plasma was implemented for realizing hydrophilicity of capacitor surface to ensure that the biosensor can be touched rapidly with glucose. Based on above implementation, a non-invasive biosensor having an ultrafast response time of superior to 0.85 s, ultralow LOD of 8.01 mg/dL and excellent reusability verified through five sets of measurements are realized. The proposed approaches are not limited the development of a stable and accurate platform for the detection of glucose levels but also presents a scheme toward the detection of glucose levels in human serum.

Highlights

  • Diabetes is a group of lifelong metabolic diseases caused by multiple etiologies, which is characterized by chronic hyperglycemia

  • We developed a non-invasive radio frequency (RF) glucose sensor based on quantitative detection

  • 4a–c presents the surface roughnesses layers measured by atomic force microscope (AFM) which are as-fabricated and etched based on Cl2 /Ar of the topprocessing

Read more

Summary

Introduction

Diabetes is a group of lifelong metabolic diseases caused by multiple etiologies, which is characterized by chronic hyperglycemia. According to the World Health Organization statistics, diabetes, having more than 100 diabetes complications is one of the most complicated diseases. Patients with amputation due to diabetes are 10 to 20 times more numerous than non-diabetic patients. Clinical data show that 30~40% of patients have at least one complication after the onset of diabetes around 10 years, and drug treatment is difficult to recover since complications occur [6]. The glucose biosensing detection system composed of bio-sensing detection conversion and peripheral electronic systems can be applied to monitor the glucose concentration of diabetic patients in time. Biosensing detection conversion plays a very important role in the sensing system, which determines several key factors, such as accuracy, detection time and system cost [7–9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call